Schramme, F., Crosignani, S., Frederix, K., Hoffmann, D., Pilotte, L., Stroobant, V., . . . Van Den Eynde, B. (2019). Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors. American Association for Cancer Research.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিSchramme, F., S. Crosignani, K. Frederix, D. Hoffmann, L. Pilotte, V. Stroobant, J. Preillon, G. Driessens, এবং B. Van Den Eynde. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিSchramme, F., et al. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.